Loblaw Companies (OTCMKTS:LBLCF) Issues Earnings Results, Misses Expectations By $0.01 EPS

Loblaw Companies (OTCMKTS:LBLCF) posted its earnings results on Thursday. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.46 by ($0.01), Zacks reports. The company had revenue of $10.59 billion during the quarter, compared to analysts’ expectations of $10.61 billion. Loblaw Companies had a net margin of 4.28% and a return on equity of 25.59%.

Loblaw Companies Stock Up 1.0%

Shares of OTCMKTS:LBLCF traded up $0.48 during trading on Friday, reaching $47.30. The stock had a trading volume of 129,394 shares, compared to its average volume of 82,571. The firm’s 50-day simple moving average is $45.75 and its 200 day simple moving average is $46.00. Loblaw Companies has a one year low of $38.08 and a one year high of $50.29. The company has a current ratio of 1.09, a quick ratio of 0.61 and a debt-to-equity ratio of 1.37. The company has a market capitalization of $54.71 billion and a P/E ratio of 27.99.

Key Loblaw Companies News

Here are the key news stories impacting Loblaw Companies this week:

• Positive Sentiment: Loblaw reported second-quarter revenue growth of 4.1%, while adjusted diluted earnings per share increased 11.9%. Management characterized the results as strong ahead of the completed sale of PC Financial. Loblaw Reports Second Quarter Revenue Growth
• Positive Sentiment: Quarterly revenue reportedly reached approximately $15.05 billion, supported by food-sales growth, store expansion and consumers trading down to Loblaw’s lower-priced offerings. This positions the company as a potential beneficiary of continued value-seeking behavior. Loblaw Revenue and Food Sales Climb
• Positive Sentiment: Shoppers Drug Mart benefited from demand for generic GLP-1 medications, while pharmacy-care expansion could provide additional traffic and revenue opportunities. Loblaw Boosts Profit on Generic GLP-1 Drug Sales
• Neutral Sentiment: Analyst commentary remains constructive on Loblaw, reflecting its defensive grocery and pharmacy exposure, though valuation and broader consumer-spending trends remain considerations. Analysts Are Bullish on Loblaw
• Negative Sentiment: Reported EPS of $0.45 narrowly missed the $0.46 consensus estimate, and revenue of $10.59 billion in one earnings release was slightly below the $10.61 billion forecast. Continued consumer trading-down may also pressure margins despite supporting sales. Loblaw Quarterly Earnings Results

Loblaw Companies Company Profile

Loblaw Companies Limited is Canada’s largest food and pharmacy retailer, operating a network of more than 2,400 corporate and franchise stores across every province and territory. Its grocery banners include Loblaws, No Frills, Real Canadian Superstore and Zehrs, while its joint venture with George Weston Limited underpins a portfolio of hard-discount and premium formats. Loblaw maintains its headquarters in Brampton, Ontario, and its shares trade on the Toronto Stock Exchange, with American depositary receipts quoted on OTCMKTS under the symbol LBLCF.

In addition to conventional grocery retailing, Loblaw provides pharmacy services through its Shoppers Drug Mart chain, one of Canada’s leading health and beauty networks.